Clinical Trials on Non-Muscle- Invasive Bladder Cancer

Total 9242 results

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Recruiting

A Study of SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects With Papillary-Only NMIBC (NiBladder 2)

Papillary-Only Non-muscle-invasive Bladder Cancer

China
Jecho Biopharmaceuticals Co., Ltd.

Recruiting

A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer. (JL19001-NMIBC)

High Risk Non-muscle Invasive Bladder Cancer

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy

High-risk Non-muscle-invasive Bladder Cancer

China
Aura Biosciences

Active, not recruiting

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Urothelial Carcinoma Bladder | NMIBC | Non-muscle-invasive Bladder Cancer | Non-Muscle Invasive Bladder Urothelial Carcinoma | Non-Muscle Invasive Bladder Neoplasms | Non-Muscle Invasive Bladder Carcinoma

United States, Australia
CAMC Health System
West Virginia Clinical and Translational Science Institute

Not yet recruiting

Feasibility of HISA During TURBT for NMIBC

Bladder Cancer | Non-muscle Invasive Bladder Cancer | Transurethral Resection of the Bladder | Non-muscle Invasive Bladder Cancer (NMIBC) | Transurethral Resection of Bladdertumors | Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) | Non-Muscle Invasive Bladder Neoplasms and other conditions

United States

Clinical Trials on Non-Muscle- Invasive Bladder Cancer

This is a preview